CAS 313674-97-4

2-({4-[2-(3,4-dichlorophenyl)ethyl]phenyl}amino)benzoic acid

Description:

2-({4-[2-(3,4-dichlorophenyl)ethyl]phenyl}amino)benzoic acid, identified by its CAS number 313674-97-4, is a chemical compound characterized by its complex structure, which includes an amino group and a benzoic acid moiety. This compound features a dichlorophenyl group, contributing to its potential biological activity and lipophilicity. The presence of the amino group suggests that it may participate in hydrogen bonding, influencing its solubility and reactivity. The benzoic acid component indicates that it can act as a weak acid, capable of donating a proton in solution. This compound may exhibit various pharmacological properties, making it of interest in medicinal chemistry. Its structural features suggest potential interactions with biological targets, which could be explored for therapeutic applications. Overall, the characteristics of this compound highlight its potential utility in drug development and research, particularly in the context of compounds that exhibit specific biological activities.

Formula: C₂₁H₁₇Cl₂NO₂

InChI: InChI=1/C21H17Cl2NO2/c22-18-12-9-15(13-19(18)23)6-5-14-7-10-16(11-8-14)24-20-4-2-1-3-17(20)21(25)26/h1-4,7-13,24H,5-6H2,(H,25,26)

SMILES: c1ccc(c(c1)C(=O)O)Nc1ccc(CCc2ccc(c(c2)Cl)Cl)cc1

Synonyms:

• 2-(4-(2-(3,4-Dichlorophenyl)Ethyl)Phenylamino)Benzoic Acid

PD-118057

CAS: 313674-97-4

PD-118057

Purity: ≥98%

Molecular weight: 386.27g/mol

Ref: 54-BUP09619

PD-118057

CAS: 313674-97-4

Formula: C₂₁H₁₇Cl₂NO₂

Molecular weight: 386.27

Ref: 7W-GL6070

PD 118057

CAS: 313674-97-4

PD 118057 is a drug that is used to treat congestive heart failure. It is an inhibitor of histone deacetylase (HDAC) and has been shown to be effective in experimental models of cardiac hypertrophy. The drug has been shown to have a depressant effect on the heart, which may be due to its ability to inhibit the production of potassium ion channels that are responsible for maintaining the resting membrane potential. PD 118057 has also been shown to decrease the number of damaged ventricular myocytes in animal models.

Formula: C₂₁H₁₇Cl₂NO₂

Purity: Min. 95%

Molecular weight: 386.27 g/mol

Ref: 3D-NMA67497

PD-118057

CAS: 313674-97-4

PD-118057, a potent hERG activator, may treat long QT syndrome and heart failure without hERG activity inhibition.

Formula: C₂₁H₁₇Cl₂NO₂

Purity: 99.16% - 99.97%

Color and Shape: Solid

Molecular weight: 386.27

Ref: TM-T16444